Protein kinase a activity and anchoring are required for ovarian cancer cell migration and invasion

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  McKenzie, Andrew J ^a   Campbell, Shirley L ^a,b   Howe, Alan K ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE 2; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; ENZYMIC BIOSENSOR; EXTRACELLULAR MATRIX; OVARY CANCER; PROTEIN INTERACTION; UPREGULATION; ANIMAL; CELL MOTION; CELL STRAIN COS1; CERCOPITHECUS; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; HUMAN; METABOLISM; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

A KINASE ANCHOR PROTEINS; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASE TYPE II; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPITHELIAL CELLS; FEMALE; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; UP-REGULATION;

EID: 80054791583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026552     Document Type: Article

References (71)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Naora H, Montell DJ, (2005) Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 5: 355-366.
3. Gubbels JA, Claussen N, Kapur AK, Connor JP, Patankar MS, (2010) The detection, treatment, and biology of epithelial ovarian cancer. J Ovarian Res 3: 8.
4. Cramer DW, Bast RC Jr, Berg CD, Diamandis EP, Godwin AK, et al. (2011) Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) 4: 365-374.
5. Dutta S, Wang FQ, Phalen A, Fishman DA, (2010) Biomarkers for ovarian cancer detection and therapy. Cancer Biol Ther 9: 668-677.
6. Mai PL, Wentzensen N, Greene MH, (2011) Challenges related to developing serum-based biomarkers for early ovarian cancer detection. Cancer Prev Res (Phila) 4: 303-306.
7. Hanprasertpong J, Fujiwara K, (2011) Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review. Eur J Cancer Care (Engl) 20: 287-293.
8. Ramirez I, Chon HS, Apte SM, (2011) The role of surgery in the management of epithelial ovarian cancer. Cancer Control 18: 22-30.
9. Pignata S, Cannella L, Leopardo D, Pisano C, Bruni GS, et al. (2011) Chemotherapy in epithelial ovarian cancer. Cancer Lett 303: 73-83.
10. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, et al. (2003) Cell migration: integrating signals from front to back. Science 302: 1704-1709.
11. Schafer C, Born S, Mohl C, Houben S, Kirchgessner N, et al. (2010) The key feature for early migratory processes: Dependence of adhesion, actin bundles, force generation and transmission on filopodia. Cell Adh Migr 4: 215-225.
12. Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Segall JE, (2007) Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 12: 143-152.
13. Howe AK, Baldor LC, Hogan BP, (2005) Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc Natl Acad Sci U S A 102: 14320-14325.
14. Deming PB, Campbell SL, Baldor LC, Howe AK, (2008) Protein kinase A regulates 3-phosphatidylinositide dynamics during platelet-derived growth factor-induced membrane ruffling and chemotaxis. J Biol Chem 283: 35199-35211.
15. Rivard RL, Birger M, Gaston KJ, Howe AK, (2009) AKAP-independent localization of type-II protein kinase A to dynamic actin microspikes. Cell Motil Cytoskeleton 66: 693-709.
16. Howe AK, (2004) Regulation of actin-based cell migration by cAMP/PKA. Biochim Biophys Acta 1692: 159-174.
17. Ydrenius L, Molony L, Ng-Sikorski J, Andersson T, (1997) Dual action of cAMP-dependent protein kinase on granulocyte movement. Biochem Biophys Res Commun 235: 445-450.
18. Edin ML, Howe AK, Juliano RL, (2001) Inhibition of PKA blocks fibroblast migration in response to growth factors. Exp Cell Res 270: 214-222.
19. Wong W, Scott JD, (2004) AKAP signalling complexes: focal points in space and time. Nat Rev Mol Cell Biol 5: 959-970.
20. Skroblin P, Grossmann S, Schafer G, Rosenthal W, Klussmann E, (2010) Mechanisms of protein kinase a anchoring. Int Rev Cell Mol Biol 283: 235-330.
21. Lim CJ, Kain KH, Tkachenko E, Goldfinger LE, Gutierrez E, et al. (2008) Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol Biol Cell 19: 4930-4941.
22. Paulucci-Holthauzen AA, Vergara LA, Bellot LJ, Canton D, Scott JD, et al. (2009) Spatial distribution of protein kinase A activity during cell migration is mediated by A-kinase anchoring protein AKAP Lbc. J Biol Chem 284: 5956-5967.
23. Howe AK, (2011) Cross-talk between calcium and protein kinase A in the regulation of cell migration. Curr Opin Cell Biol 23 in press.
24. Diviani D, Scott JD, (2001) AKAP signaling complexes at the cytoskeleton. J Cell Sci 114: 1431-1437.
25. Bai F, Feng J, Cheng Y, Shi J, Yang R, et al. (2006) Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials. Int J Gynecol Cancer 16: 202-209.
26. Alper O, Hacker NF, Cho-Chung YS, (1999) Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. Oncogene 18: 4999-5004.
27. McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, et al. (1999) Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. Br J Cancer 79: 933-939.
28. Cheadle C, Nesterova M, Watkins T, Barnes KC, Hall JC, et al. (2008) Regulatory subunits of PKA define an axis of cellular proliferation/differentiation in ovarian cancer cells. BMC Med Genomics 1: 43.
29. Hasegawa K, Ono T, Matsushita H, Shimono M, Noguchi Y, et al. (2004) A-kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis. Int J Cancer 108: 86-90.
30. Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, et al. (2005) A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer. Gynecol Oncol 99: 183-188.
31. Lochner A, Moolman JA, (2006) The many faces of H89: a review. Cardiovasc Drug Rev 24: 261-274.
32. Gold MG, Lygren B, Dokurno P, Hoshi N, McConnachie G, et al. (2006) Molecular basis of AKAP specificity for PKA regulatory subunits. Mol Cell 24: 383-395.
33. Hundsrucker C, Rosenthal W, Klussmann E, (2006) Peptides for disruption of PKA anchoring. Biochem Soc Trans 34: 472-473.
34. Carlson CR, Lygren B, Berge T, Hoshi N, Wong W, et al. (2006) Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem 281: 21535-21545.
35. Ni Q, Titov DV, Zhang J, (2006) Analyzing protein kinase dynamics in living cells with FRET reporters. Methods 40: 279-286.
36. Allen MD, Zhang J, (2006) Subcellular dynamics of protein kinase A activity visualized by FRET-based reporters. Biochem Biophys Res Commun 348: 716-721.
37. Jones SL, Sharief Y, (2005) Asymmetrical protein kinase A activity establishes neutrophil cytoskeletal polarity and enables chemotaxis. J Leukoc Biol 78: 248-258.
38. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, et al. (1999) Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112 (Pt 24): 4615-4625.
39. Lim CJ, Han J, Yousefi N, Ma Y, Amieux PS, et al. (2007) Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins. Nat Cell Biol 9: 415-421.
40. Lengyel E, (2010) Ovarian cancer development and metastasis. Am J Pathol 177: 1053-1064.
41. Even-Ram S, Yamada KM, (2005) Cell migration in 3D matrix. Curr Opin Cell Biol 17: 524-532.
42. Petrie RJ, Doyle AD, Yamada KM, (2009) Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10: 538-549.
43. Friedl P, Wolf K, (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
44. Yilmaz M, Christofori G, (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8: 629-642.
45. Kam Y, Guess C, Estrada L, Weidow B, Quaranta V, (2008) A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro. BMC Cancer 8: 198.
46. Capo-chichi CD, Cai KQ, Testa JR, Godwin AK, Xu XX, (2009) Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol Cell Biol 29: 4766-4777.
47. Cho-Chung YS, Pepe S, Clair T, Budillon A, Nesterova M, (1995) cAMP-dependent protein kinase: role in normal and malignant growth. Crit Rev Oncol Hematol 21: 33-61.
48. Bossis I, Stratakis CA, (2004) Minireview: PRKAR1A: normal and abnormal functions. Endocrinology 145: 5452-5458.
49. Naviglio S, Caraglia M, Abbruzzese A, Chiosi E, Di Gesto D, et al. (2009) Protein kinase A as a biological target in cancer therapy. Expert Opin Ther Targets 13: 83-92.
50. Young MR, Montpetit M, Lozano Y, Djordjevic A, Devata S, et al. (1995) Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A. Int J Cancer 61: 104-109.
51. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, et al. (2007) The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 18: 1768-1780.
52. Choi JH, Choi KC, Auersperg N, Leung PC, (2006) Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells. Cancer Res 66: 3912-3920.
53. Sabbisetti VS, Chirugupati S, Thomas S, Vaidya KS, Reardon D, et al. (2005) Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer 117: 551-560.
54. Dabizzi S, Noci I, Borri P, Borrani E, Giachi M, et al. (2003) Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A. Cancer Res 63: 4281-4286.
55. Zhang D, Ouyang J, Wang N, Zhang Y, Bie J, (2010) Promotion of PDGF-induced endothelial cell migration by phosphorylated VASP depends on PKA anchoring via AKAP. Mol Cell Biochem 335: 1-11.
56. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, et al. (2010) Integrative genome comparison of primary and metastatic melanomas. PLoS One 5: e10770.
57. Xia W, Unger P, Miller L, Nelson J, Gelman IH, (2001) The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 61: 5644-5651.
58. Su B, Bu Y, Engelberg D, Gelman IH, (2010) SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. J Biol Chem 285: 4578-4586.
59. Iwashita S, Fujii M, Mukai H, Ono Y, Miyamoto M, (2004) Lbc proto-oncogene product binds to and could be negatively regulated by metastasis suppressor nm23-H2. Biochem Biophys Res Commun 320: 1063-1068.
60. Curto M, McClatchey AI, (2004) Ezrin...a metastatic detERMinant? Cancer Cell 5: 113-114.
61. Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI, (2003) NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev 17: 1090-1100.
62. Estecha A, Sanchez-Martin L, Puig-Kroger A, Bartolome RA, Teixido J, et al. (2009) Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion. J Cell Sci 122: 3492-3501.
63. Fernando HS, Sanders AJ, Kynaston HG, Jiang WG, (2008) WAVE1 is associated with invasiveness and growth of prostate cancer cells. J Urol 180: 1515-1521.
64. Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T, (2005) Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24: 1309-1319.
65. Pidoux G, Tasken K, (2010) Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins. J Mol Endocrinol 44: 271-284.
66. Hochbaum D, Barila G, Ribeiro-Neto F, Altschuler DL, (2011) Radixin assembles cAMP effectors Epac and PKA into a functional cAMP compartment: role in cAMP-dependent cell proliferation. J Biol Chem 286: 859-866.
67. Breckler M, Berthouze M, Laurent AC, Crozatier B, Morel E, et al. (2011) Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. Cell Signal 23: 1257-1266.
68. Lyle KS, Raaijmakers JH, Bruinsma W, Bos JL, de Rooij J, (2008) cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell Signal 20: 1104-1116.
69. Bos JL, (2006) Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31: 680-686.
70. Kenny HA, Krausz T, Yamada SD, Lengyel E, (2007) Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer 121: 1463-1472.
71. Shield K, Ackland ML, Ahmed N, Rice GE, (2009) Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol Oncol 113: 143-148.